Genomas Inc., a Hartford, Conn.-based biomedical company focused on DNA-guided medicine and personalized health, has raised $2.5 million in Series C funding, according to a regulatory filing. Shareholders include
Genomas Adds $2.5 Million
Genomas Inc., a Hartford, Conn.-based biomedical company focused on DNA-guided medicine and personalized health, has raised $2.5 million in Series C funding, according to a regulatory filing. Shareholders include
Copyright PEI Media
Not for publication, email or dissemination
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.